TOPIC

Biomedicine: Science

Related Topics:
Biomedicine: Companies
Biomedicine: Policy
Biomedicine: Science
Biomedicine: Industry Trends
Biomedicine: Geopolitics
Biomedicine: Science
Learn about China’s biomedical breakthroughs, from cutting-edge pharmaceuticals to life-saving research, driving global health innovation.
Illustration by Henry Wong.
Biomedicine: Companies

Chinese biotech firms eye foreign pharma’s fat profits in weight loss drug market

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US drugmakers.

Artificial intelligence

Hong Kong’s IntelliGen AI takes on Google DeepMind in drug discovery

Biomedicine: Companies

Explainer | Why dozens of Chinese firms are joining the weight loss drugs fray

Science

Mammals could regenerate tissue by turning on ‘genetic switch’: Chinese team

Scientists studying ability of mice to regenerate ear damage say therapies based on retinoic acid might work across various tissue types.

videocam
Chinese scientists studying regeneration say a mouse’s failure to regenerate stems from an inability to produce sufficient retinoic acid, a derivative of vitamin A. Photo: Shutterstock
Biomedicine: Companies

China’s drug innovators bank on AI to hasten discovery to commercial success

A deal between Shenzhen-based XTalPi and US firm DoveTree shows Chinese biotech AI capabilities are gaining recognition.

videocam
Health & Fitness

MingMed seeks Hong Kong listing to fund research and launch Botox alternative

Drug developer says it will set up an incubation centre in the Hong Kong Science and Technology Park in the third quarter.

Advertisement
Advertisement
Advertisement
Hong Kong economy

Opinion | Hong Kong must reform its degree offerings to attract West’s brightest

Universities must evolve and burnish their offerings in the latest disciplines, from AI to cybersecurity, as US crackdowns send more to the East.

videocam
University of Hong Kong students work on a groundbreaking diamond membrane technology on December 19, paving the way for its mass production and widespread use in electronics. Photo: Holly Chik
Artificial intelligence

Biotech firm touts new AI drug discovery amid third Hong Kong IPO attempt

Insilico Medicine said results of a clinical trial in China showed positive results in treating idiopathic pulmonary fibrosis.

Science

China boosts Southeast Asian populations overlooked in Human Genome Project

Before China took a role in the research, fewer than 200 indigenous genomes from MSEA existed in global databases, according to Nature paper.

videocam
Biomedicine: Companies

Chinese biotech firm Akeso sinks after US partner’s cancer-drug setback

FDA says a ‘statistically significant’ benefit on overall survival is required to approve the ivonescimab antibody.

Akeso’s clinical trials in China showed that ivonescimab allowed half of its patients to go 11.1 months without their cancer progressing. Photo: Shutterstock
Artificial intelligence

XPrize founder Diamandis projects hope for AI, biotech amid US-China tech war

The entrepreneur says biotech should be less contentious than AI, as a breakthrough in Beijing is just as usable in Boston.

videocam
XPrize Foundation founder Peter Diamandis poses at the Four Seasons while attending the UBS Asia Investment Conference on May 28. Photo: Matt Haldane
Robotics

Hong Kong surgical robot start-up Cornerstone takes aim at da Vinci

Company aims to raise US$70 million to develop its systems, which it claims rival the market-leading da Vinci units at lower cost.

Biomedicine: Companies

Chinese biotech firm secures Pfizer deal despite trade tensions

Pfizer will produce the drug, which targets lung and colorectal cancers, in the US and take a US$100 million stake in China’s 3SBio.

videocam
Biomedicine: Companies

Hong Kong’s Phase Scientific gets US$34 million to advance test for HPV

Company says its test is the world’s first urine-based screening for the virus that causes 95 per cent of cervical cancer cases.

Ricky Chiu Yin-to, founder, chairman and CEO of Hong Kong biotech company Phase Scientific. Photo: Handout
Biomedicine: Companies

China’s weight-loss drug market to lure entrants as Eli Lilly, Novo dominate

Drug manufacturers to focus on China and Japan, where penetration is low and innovation continues to emerge, Morgan Stanley says.

videocam
The market for weight-loss drugs could see new entrants among existing biotech firms. Photo: Shutterstock
Artificial intelligence

Hong Kong healthcare investor looks for biotech’s ‘DeepSeek moment’ in China

ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market.

United States

Opinion | Trump’s attack on science risks dismantling a century of innovation

Restrictive visa policies, rhetoric targeting academic institutions and proposed budget cuts to scientific agencies mark the start of US retreat.

videocam
Advertisement
Advertisement
Advertisement
Science

Drug trial offers hope for patients with hard-to-treat lung cancer in China, US

New medication appears to be safer and more effective than standard therapy, according to trial led by Chinese and US scientists.

videocam
7
Lung cancer is the most prevalent type of the disease worldwide, with an estimated 2.5 million new cases globally last year. Photo: PR NEWSWIRE
Biomedicine: Companies

Pharus, an AI-powered cancer test developer, taps Hong Kong funds

Pharus Diagnostics, backed by Li Ka-shing, seeks Hong Kong funds for AI-driven cancer tests.

Quantum computing

Chinese quantum computing firm tackles breast cancer screenings, drug design

Hefei-based Origin Quantum has demonstrated its computer’s ability to process medical imaging data ‘exponentially faster’ than classical machines.

China property

Beijing, Shanghai lead global construction of life sciences centres, CBRE says

Construction of nearly 14 million sq ft of R&D facilities is under way in China’s top two cities, report says.

The Zhongguancun life science park in Beijing. China leads the world in the construction of life science facilities, according to CBRE. Photo: Handout
Science

Beijing almost ready to switch on world’s most powerful X-ray light source

As construction finishes on China’s High Energy Photon Source, scientists are lining up to use it to further their research.

videocam
10
China’s High Energy Photon Source, an X-ray light source that will be able to generate beams with a photon density a trillion times brighter than the surface of the sun, has entered its final phase of construction. Photo: Chinese Academy of Sciences
Hong Kong

This week in PostMag: from André Fu’s designs to stem cell therapy

Stunt double Jason Li talks about his journey from squash courts to the set of Transformers while we look at Fu’s Dusit Thani Bangkok project.

Science

What if curing cancer could cost 99% less in China?

Chinese biotech start-ups are going up against Western drug makers – and they could win.

videocam
38
Science

Chinese breakthrough challenges Elon Musk’s verdict on paralysed patients

Patients with spinal cord injuries have been offered the chance to walk again after the success of a Chinese trial.

videocam
19
Four patients with spinal cord injuries were able to move their limbs hours after groundbreaking surgery as part of a clinical trial led by Shanghai’s Fudan University. Photo: Fudan University
Science

China-led team uses 3D-printed male sex organ for ED treatment in world first

Chinese-led team uses hydrogel-based bioinks for 3D-printed implant able to replicate functional components of natural erectile tissue.

videocam
More than 40 per cent of men aged 40 and above are said to have erectile dysfunction. Photo: Shutterstock
Hong Kong

She tried several careers but found her niche in genetic sequencing

PostMag talks to 5 women innovators at the top of their game and pushing the boundaries of scientific discovery – here we meet Angela Wu, a professor at HKUST’s division of life science and department of chemical and biological engineering.

Cancer

Groundbreaking cancer therapies are the goal for this biotech innovator

PostMag talks to 5 women innovators at the top of their game and pushing the boundaries of scientific discovery: here we meet Gina Jiang, managing director of the Hong Kong Institute of Biotechnology.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement